Ophthalmology Product Articles & Analysis

1 news found

BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome

(“BRIM”) a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. ...

May 17, 2022

ByBRIM Biotechnology, Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you